Dubai, United Arab Emirates: Align Technology, Inc(Nasdaq: ALGN), a leading global medical device company that designs, manufactures and sells the Invisalign® formula of transparent aligners, iTero™ intraoral scanners and exocad™ CAD/CAM software for virtual orthodontics and restorative dentistry, will host its Invisalign Scientific Symposium 2022, the company’s annual European flagship event for orthodontists, in Dubai, as the company continues its presence and commitment to orthodontists in the Middle East region.
The two-day event will take place at the Madinat Jumeirah Resort in Dubai from 9 to 10 September 2022, bringing together a diversity of foreign speakers who will lecture on key topics within the orthodontic community. Orthodontists trained in Invisalign of the East This and emea are expected in giant.
The 2022 Invisalign Scientific Symposium theme, “Patient-Centered Clinical Excellence,” will provide clinicians with clinical evidence on 3 main topics, including “the generative effect on the treatment experience,” “clinical outcomes in patient development,” and “health during and after orthodontic treatment. “One of the keynote speakers on the occasion will be Dr. Suliman Shahin, from the Kingdom of Saudi Arabia, who will represent the Middle East region and join other keynote speakers from emea.
Angelo Maura, Managing Director for the Middle East and Africa at Align Technology, said: “We are incredibly proud to host the Invisalign Science Symposium in Dubai. This is a testament to Align’s commitment to bringing best-in-class generation to our physicians in the Middle East, as well as EMEA as a whole. We hope events like those will help highlight the many benefits of virtual dentistry. Our goal is to inspire physicians to share their wisdom and reports to help them stay current and digitize their practices. “
Pierre Velu, Vice President of Sales for Align Technology, Ortho Channel for Central Europe, said: “After two online editions, it will be a great excitement to get to know many of our consumers again for the 2022 edition of the Invisalign Science Symposium. This will be a wonderful opportunity to talk and reflect on what the Invisalign clear aligner system has brought to orthodontics since its inception as we celebrate Align’s 25th anniversary this year. From the beginning, we have worked frequently to provide the most productive generation to our consumers to ensure the most productive outcomes imaginable for their patients.
To revel in learning and encourage in-depth discussions, the occasion will also feature networking sessions, as well as live demonstrations of the Invisalign transparent aligner and iTero scanner for attendees.
Scientific Symposium Award 2022
The Best of Scientific Symposium 2022 will praise one of the Symposium’s speakers for the most productive presentation, relevance of the topic, and quality of research. Participants will have the opportunity to vote on the occasion to choose the winner.
Align will also highlight orthodontic paintings by graduate students, with the new EMEA Emerging Leader Award category, to be awarded for the first time. This award is designed to assist emerging professionals in projects focused on orthodontic remedy with clear aligner therapy. The winner will be decided before the Symposium through an external clinical committee composed of Dr. Esmeralda Herrero (Spain), Prof. Padhraig Fleming (United Kingdom) and Prof. Luca Levrini (Italy) and will have the opportunity to contribute his paintings in the moment. day of the Symposium.
Virtual occasion available on request.
The recording of the event will be available upon request to give physicians full flexibility to view the presentations at their convenience, which they can access by registering on the Invisalign Scientific Symposium website.
The recordings will be uploaded to the Invisalign Doctor online page and will be available for a period of one year, to registered physicians.
To learn more and register for the Invisalign Science Symposium, visit the website for the event.
Disclaimer: The content of this press release has been provided through a third-party third-party provider. This online page is not guilty of this external content and does not. This content is provided on an “as is” and “as available” basis and has not been modified in any way. Neither this online page nor our affiliates warrant the accuracy or endorse the perspectives or reviews expressed in this press release.
The press release is provided for informational purposes only. The Content does not provide tax, legal or investment recommendations or reviews relating to the suitability, price or return of any specific security, portfolio or investment strategy. Neither this nor our affiliates will be held responsible for errors or inaccuracies in the content, or for any action taken through you based thereon. You expressly agree that your use of the data contained in this segment is at your own risk.
To the fullest extent permitted by applicable law, this website, its parent company, subsidiaries, affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors shall be liable (jointly or individually) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including, but not limited to, lost profits, loss of savings and loss of revenue, whether by negligence, tort, contract, or any other theory of liability, even if the parties have requested the option or may simply have foreseen such damages.